(3-(N-(4-Methoxybenzyl)sulfamoyl)phenyl)boronic acid, 95.0%, 250mg

Ethyl 6-bromoindolizine-2-carboxylate, 95.0%, 250mg

2-[1-Methyl-3-(trifluoromethyl)pyrazol-5-yl]-thiophene-5-carboxylic acid, 250mg

N-{1-[(2-Chlorophenyl)amino]-2-(4-methylphenyl)-2-oxoethyl}furan-2-carboxamide, 10mg

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2,4-dimethylpentanoic acid, 95.0%, 25g

5,6-Dimethyl-2-oxo-1,2-dihydropyridine-3-carboxylic acid, 95.0%, 1g

(3aR,7aS)-2-Benzylhexahydropyrano[3,4-c]pyrrol-4(1H)-one, 95%, 250mg

trans-tert-Butyl (4-fluoropiperidin-3-yl)carbamate, 95.0%, 5g

(4-Cyclopropyl-4-methyl-2,5-dioxo-imidazolidin-1-yl)-acetic acid, 100mg

Copper(I) Trifluoromethanesulfonate Benzene Complex>90.0%(T)5g

3-Amino-4-[(pyridin-3-ylmethyl)-amino]-benzoic acid, 95.0%, 1g

Vinyl terminated (15-17% diphenylsiloxane)-dimethylsiloxane copolymer, 1,000 cst, 100g

[(5,7-dimethylimidazo[1,2-a]pyridin-2-yl)methyl]amine dihydrochloride dihydrate, 95.0%, 1g